Schedule 13G ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2018-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
662,900
Percent of class
3.6700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-055945
Form type
SC 13G/A
Filer
Salarius Pharmaceuticals, Inc.
CIK
CIK 1615219
Filed
Sep 10, 2018
Reporting period
Aug 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub